Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
World Psychiatry · 2023-10 · 22 (3) · 366-387
DOI: 10.1002/wps.21110 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Psychiatry, online erschienen am 15.09.2023. Verfasst von Michael Berk und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, VIC, Australia. Die Arbeit wurde bisher 349-mal zitiert (Crossref) und nennt 373 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Populations with common physical diseases – such as cardiovascular diseases, cancer and neurodegenerative disorders – experience substantially higher rates of major depressive disorder (MDD) than the general population. On the other hand, people living with MDD have a greater risk for many physical diseases. This high level of comorbidity is associated with worse outcomes, reduced adherence to treatment, increased mortality, and greater health care utilization and costs. Comorbidity can also result in a range of clinical challenges, such as a more complicated therapeutic alliance, issues pertaining to adaptive health behaviors, drug‐drug interactions and adverse events induced by medications used for physical and mental disorders. Potential explanations for the high prevalence of the above comorbidity involve shared genetic and biological pathways. These latter include inflammation, the gut microbiome, mitochondrial function and energy metabolism, hypothalamic‐pituitary‐adrenal axis dysregulation, and brain structure and function. Furthermore, MDD and physical diseases have in common several antecedents related to social factors (e.g., socioeconomic status), lifestyle variables (e.g., physical activity, diet, sleep), and stressful live events (e.g., childhood trauma). Pharmacotherapies and psychotherapies are effective treatments for comorbid MDD, and the introduction of lifestyle interventions as well as collaborative care models and digital technologies provide promising strategies for improving management. This paper aims to provide a detailed overview of the epidemiology of the comorbidity of MDD and specific physical diseases, including prevalence and bidirectional risk; of shared biological pathways potentially implicated in the pathogenesis of MDD and common physical diseases; of socio‐environmental factors that serve as both shared risk and protective factors; and of management of MDD and physical diseases, including prevention and treatment. We conclude with future directions and emerging research related to optimal care of people with comorbid MDD and physical diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, VIC, Australia.
- Psychosis Research Unit, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Psychiatry and Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
- Division of Psychology and Mental Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
- Greater Manchester Mental Health NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Förderung
- Medical Research Council
Zitieren
APA
Berk, M., Köhler-Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., Plana-Ripoll, O., O'Neil, A., Siskind, D., Williams, L. J., Carvalho, A. F., Schmaal, L., Walker, A. J., Dean, O., Walder, K., …, & Marx, W. (2023). Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry, 22(3), 366-387. https://doi.org/10.1002/wps.21110
Vancouver
Berk M, Köhler-Forsberg O, Turner M, Penninx BWJH, Wrobel A, Firth J, et al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023;22(3):366-387. doi:10.1002/wps.21110
BibTeX
@article{Berk2023,
author = {Berk, Michael and Köhler-Forsberg, Ole and Turner, Megan and Penninx, Brenda W J H and Wrobel, Anna and Firth, Joseph and Loughman, Amy and Reavley, Nicola J and McGrath, John J and Momen, Natalie C and Plana-Ripoll, Oleguer and O'Neil, Adrienne and Siskind, Dan and Williams, Lana J and Carvalho, Andre F and Schmaal, Lianne and Walker, Adam J and Dean, Olivia and Walder, Ken and Berk, Lesley and Dodd, Seetal and Yung, Alison R and Marx, Wolfgang},
title = {Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management},
journal = {World Psychiatry},
year = {2023},
volume = {22},
number = {3},
pages = {366--387},
doi = {10.1002/wps.21110}
}
EUVIMED